| Product |
CAS |
Molecular formula |
More |
| [1,1’-Biphenyl]-4-carboxylic acid (3ar,4r,5r,6as)-hexahydro-2-oxo-4- |
41639-72-9 |
C31H28O5 |
More |
| 13-Ethyl-11-methylene-gon-4-en-17-one |
54024-21-4 |
C20H28O |
More |
| Dimyristoylphosphatidylglycerol |
61361-72-6 |
C34H67O10P |
More |
| Ditallowdimethylammoniumchloride,hydrogenatedform |
61789-80-8 |
|
More |
| 3,3’-(1,4-Phenylenedi-2,1-ethenediyl)bis(9-ethyl-9h-carbazole) |
62608-15-5 |
C38H32N2 |
More |
| 6’-(Ethyl-(3-methylbutyl)amino)-3’-methyl-2’-(phenylamino)spiro[ |
70516-41-5 |
C34H34N2O3 |
More |
| Adenosine 5’-diphosphate monopotassium salt |
72696-48-1 |
C10H15N5O10P2.2H2O.K |
More |
| Norastemizole hydrobromide |
75970-64-8 |
C19H21FN4.2BrH |
More |
| Diacetato[(s)-(-)-2,2-bis(di-p-tolylphosphino)-1,1-binaphthyl]rutheniu |
106681-15-6 |
C52H46O4P2Ru |
More |
| Methyl13-cis,16-cis,19-cis-docosatrienoate |
108698-01-7 |
C23H40O2 |
More |
| Diacetato[(s)-(-)-2,2-bis(di-p-tolylphosphino)-1,1-binaphthyl]rutheniu |
116128-29-1 |
C52H46O4P2Ru |
More |
| Utp |
116295-90-0 |
C9H15N2O15P3.2H2O.3Na |
More |
| [2,2-Bipyridine]-4,4-dicarboxylic acid, 6,6-dimethyl-, 4,4-dimethyl es |
117330-40-2 |
C16H16N2O4 |
More |
| Ru phosphoramidite |
118362-03-1 |
C45H61N4O9PSi |
More |
| (R)-(+)-2,2’-bis(diphenylphosphino)-1,1’-binaphthalenechloro(p-cym |
145926-28-9 |
C54H46ClP2RuCl |
More |
| 5-O-(4,4-dimethoxytrityl)-2-deoxy-2-fluorouridine-3-(2-cyanoethyl-n,n- |
146954-75-8 |
C39H46FN4O8P |
More |
| 5,5’,6,6’-Tetrahydroxy-3,3,3’,3’-tetramethyl-1,1’-spirobiind |
77-08-7 |
C21H24O4 |
More |
| Sodium 2-(3-fluoro-4-phenylphenyl)propanoate dihydrate |
56767-76-1 |
C15H13FO2.Na |
More |
| Irbesartan related compound a (25 mg) (1-pentanoylamino-cyclopentaneca |
748812-53-5 |
C25H30N6O2 |
More |
| 3,3’-(3,3’-Dimethoxy-4,4’-diphenylene)bis(2-phenyl-5-veratryltet |
106629-90-7 |
C46H44N8O6.2Cl |
More |
